Northwest Biotherapeutics Inc NWBO

Healthcare Biotechnology

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.

OTCQB:NWBO - Post by User

Northwest Biotherapeutics Inc

Bullboard Posts

Comment by pericles1on Jun 06, 2015 7:36am

102 Views

Post# 23803346

RE:RE:Pyro on I-Hub

Thanks for posting, yes I believe you are correct. Pyrr is an excellent writer he actually makes AF look like a child. When he was very bullish and everyone was praising him I thought he was to bullish at the time. Now he turned negative he's one of these people who when he makes up his mind he only grabs information that agrees with his current opinion. I personally think the difference between A and B are stunning and not cherry picked. I think PHASE ii will show that we can give a lot of people a great deal of extra quality time and will be a major accomplishment. I don't know how many we can cure but it is still GREAT!

Bullboard Posts

Gold vs. bitcoin, where should you invest?